Wall Street Analysts Think ALX Oncology Holdings (ALXO) Could Surge 36.64%: Read This Before Placing a Bet

Group 1: Stock Performance and Price Targets - ALX Oncology Holdings Inc. (ALXO) closed at $15.61, with a 21.1% gain over the past four weeks, and a mean price target of $21.33 indicating a 36.6% upside potential [1] - The mean estimate includes six short-term price targets with a standard deviation of $4.59, suggesting variability in analyst estimates; the lowest estimate is $14 (10.3% decline), while the highest is $27 (73% increase) [1][4] - A tight clustering of price targets, indicated by a low standard deviation, suggests a high degree of agreement among analysts regarding the stock's price movement [4] Group 2: Analyst Sentiment and Earnings Estimates - Analysts show increasing optimism about ALXO's earnings prospects, with a strong agreement in revising EPS estimates higher, correlating with potential stock price increases [6] - Over the last 30 days, three estimates have been revised upward, leading to a 9.1% increase in the Zacks Consensus Estimate [6] - ALXO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential upside [7]